Vitreoretinal Surgery Devices Market Size, Share and Global Trend By Components (Endoillumination Instruments, Vitreoretinal Prefilled Silicone Oil Syringe, Vitreoretinal Perfluorocarbon Liquid), By Surgery Type (Anterior Vitreoretinal Surgery, Posterior Vitreoretinal Surgery), By End User (Hospitals, Eye Institutes, Ambulatory Surgery Centers) and Regional Forecast, 2024-2032

The global burden of eye disorders is addressed by eye surgeries assisted with latest automated technological devices. In July 2018, Alcon launched, NGENUITY 3D Visualization System with aim to improve precision in vitreoretinal surgeries. Vitreoretinal surgery refers to procedures done at interior portion of the eye where the delicate gel vitreous and retina are found.

Vitreoretinal surgery is done for the treatment of complications related to macula, vitreous fluid and retina. Vitreoretinal surgery is of two types, namely anterior vitreoretinal surgery and posterior vitreoretinal surgery. Anterior vitreoretinal surgery is done when the gel-like vitreous comes into the anterior part of the eye through pupil at times of trauma or eye injury. Posterior vitreoretinal surgery is done for diseases in the posterior part of the eye.

The growth in global vitreoretinal surgery devices market is mainly driven by the increased availability of easy-to-use automated devices for eye procedures and increase in number of vitreoretinal surgeries in developed countries. Apart from these, the increase in number of ophthalmic clinics in emerging countries is also expected to boost the growth in global vitreoretinal surgery devices market during the forecast period.

The stringent government regulation due to the growing concern for patient safety is a factor which is expected to hinder the growth in global vitreoretinal surgery devices market.

Key Players Covered

Some of the major companies that are present in the global vitreoretinal surgery devices market are Bausch & Lomb Incorporated, Novartis AG (Alcon), Inami & Co., Ltd., Dutch Ophthalmic Research Center (International) BV, Paragon Care Group Pty Ltd, Oculus Inc., MedOne Surgical, Inc., Carl Zeiss Meditec AG, Peregrine Surgical and other players.

SEGMENTATION

Among the segmentation, anterior vitreoretinal surgery in the surgery type segment is expected to hold significant share owing to higher number of surgeries. Moreover, increasing prevalence of age-related macular degeneration also represents higher opportunity for registering significant CAGR during the forecast period.

Key Insights

• The regulatory scenario for key countries


• Prevalence of eye diseases for key countries


• Technological advancements in vitreoretinal surgery devices


• Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis

North America is projected to dominate the global vitreoretinal surgery devices market owing to the increasing prevalence of eye diseases and high health care expenditure. According to National Eye Institute, in 2014, an estimated 2.1 million Americans were suffering from advanced age-related muscular degeneration (AMD), which was projected to increase to 3.7 million by the year 2030, thereby booming the global vitreoretinal surgery devices market. In Europe and Asia Pacific the vitreoretinal surgery devices market is estimated to expand due to the increased government efforts for setting up of tertiary eye institutes and improving health reimbursement.

Key Industry Developments

• In September 2018, Optikon, one of the significant player in eye care market launched R-Evo smart, a compact equipment with aim to improve the quality of retinal and cataract surgeries.
• In September 2015, Valeant Pharmaceuticals (Bausch Health) acquired Synergetics USA in order to expand the customer base across extended geographical regions.